Status: current, Defined. Date: 31-Oct 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3109681000168117 | Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3109691000168119 | Quadracel injection, 0.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | Is a | Quadracel | true | Inferred relationship | Some | ||
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | Is a | diphtheria + tetanus + pertussis 5 component + polio trivalent child vaccine injection, 0.5 mL vial | true | Inferred relationship | Some | ||
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has manufactured dose form | injection suspension | false | Inferred relationship | Some | ||
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has unit of use | vial | true | Inferred relationship | Some | 1942818419 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has Australian BoSS | Bordetella pertussis filamentous haemagglutinin antigen | true | Inferred relationship | Some | 858825482 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has intended active ingredient | Bordetella pertussis filamentous haemagglutinin antigen | true | Inferred relationship | Some | 858825482 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has Australian BoSS | poliovirus type 2 inactivated antigen | true | Inferred relationship | Some | 1360771558 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has intended active ingredient | poliovirus type 2 inactivated antigen | true | Inferred relationship | Some | 1360771558 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has intended active ingredient | Bordetella pertussis fimbriae type 2 and 3 antigen | true | Inferred relationship | Some | 1942818418 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has Australian BoSS | Bordetella pertussis fimbriae type 2 and 3 antigen | true | Inferred relationship | Some | 1942818418 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has Australian BoSS | diphtheria toxoid | true | Inferred relationship | Some | 1391361100 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has intended active ingredient | diphtheria toxoid | true | Inferred relationship | Some | 1391361100 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has intended active ingredient | Bordetella pertussis pertactin antigen | true | Inferred relationship | Some | 541913504 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has Australian BoSS | Bordetella pertussis pertactin antigen | true | Inferred relationship | Some | 541913504 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has Australian BoSS | tetanus toxoid | true | Inferred relationship | Some | 1612492084 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has intended active ingredient | tetanus toxoid | true | Inferred relationship | Some | 1612492084 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has intended active ingredient | poliovirus type 3 inactivated antigen | true | Inferred relationship | Some | 1347760046 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has Australian BoSS | poliovirus type 3 inactivated antigen | true | Inferred relationship | Some | 1347760046 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has intended active ingredient | poliovirus type 1 inactivated antigen | true | Inferred relationship | Some | 132551838 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has Australian BoSS | poliovirus type 1 inactivated antigen | true | Inferred relationship | Some | 132551838 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has intended active ingredient | Bordetella pertussis toxoid | true | Inferred relationship | Some | 673294704 | |
| Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | has Australian BoSS | Bordetella pertussis toxoid | true | Inferred relationship | Some | 673294704 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Quadracel injection, 0.5 mL vial | has TPUU | True | Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
| Quadracel injection, 0.5 mL vial | has TPUU | True | Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
| Quadracel injection, 5 x 0.5 mL vials | has TPUU | True | Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
| Quadracel injection, 5 x 0.5 mL vials | has TPUU | True | Quadracel (Bordetella pertussis filamentous haemagglutinin antigen 20 microgram + Bordetella pertussis fimbriae serotype 2 and 3 antigen 5 microgram + Bordetella pertussis pertactin antigen 3 microgram + Bordetella pertussis toxoid 20 microgram + diphtheria toxoid 30 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 40 international units) injection, 0.5 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR